About the journal
International Journal of Hematologic Oncology is an open-access journal published by Future Medicine in United Kingdom. It is listed in PUBMED according to the sources read. Declared publication charge: 1,415 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Future Medicine
- ISSN
- 2045-1393 · 2045-1407
- Country
- United Kingdom
- Access
- Open access
- Declared publication charge
- 1,415 USD
- Official website
- https://www.futuremedicine.com/journal/IJH
Index listings
- PUBMED · 2013-06-01
- Indexing
- PUBMED
- APC
- 1,415 USD
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2023
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
255
Last recorded publication year
2023
h-index
16
i10-index
29
From OpenAlex open data (CC0).
Editorial & policy3
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity1
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
Show all subjects (50)
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- Protein Degradation and Inhibitors
- Protein Degradation and Inhibitors
- CAR-T cell therapy research
- CAR-T cell therapy research
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Viral-associated cancers and disorders
- Viral-associated cancers and disorders
- CNS Lymphoma Diagnosis and Treatment
- CNS Lymphoma Diagnosis and Treatment
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Histone Deacetylase Inhibitors Research
- Human auditory perception and evaluation
- Childhood Cancer Survivors' Quality of Life
- Retinoids in leukemia and cellular processes
- Neutropenia and Cancer Infections
- Childhood Cancer Survivors' Quality of Life
- Human auditory perception and evaluation
- Diverse Scientific and Economic Studies
- Histone Deacetylase Inhibitors Research
- Neutropenia and Cancer Infections
- Retinoids in leukemia and cellular processes
- Diverse Scientific and Economic Studies
- PI3K/AKT/mTOR signaling in cancer
- Cancer Treatment and Pharmacology
- PI3K/AKT/mTOR signaling in cancer
- Immune Cell Function and Interaction
- Advanced Breast Cancer Therapies
- Immune Cell Function and Interaction
- Peptidase Inhibition and Analysis
- Advanced Breast Cancer Therapies
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ